|
26 Sep 2007 |
Twinstrand Therapeutics Inc. Files IND Application For Immunogen in Ricin Antidote Study
|
|
22 Sep 2007 |
Vaccination and Enrollment Are Discontinued in Phase II Trials of Merck's Investigational HIV Vaccine Candidate
|
|
20 Sep 2007 |
FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age
|
|
20 Sep 2007 |
Dynavax's HEPLISAV(TM) Hepatitis B Vaccine Maintains Full Immunogenicity at 50 Weeks in Phase 3 Trial
|
|
19 Sep 2007 |
Iomai Patch-Based Vaccine Cut Rate of Travelers' Diarrhea by 75 Percent in Phase 2 Field Study
|
|
19 Sep 2007 |
Sanofi Pasteur's Investigational H5N1 Influenza Vaccine Achieves High Immune Response at Low Dosage
|
|
12 Sep 2007 |
Sinovac Commences Vaccination on Volunteers for Phase II Clinical Trial on Pandemic Influenza H5N1 Vaccine
|
|
12 Sep 2007 |
Oxford BioMedica Reaches First Milestone in TroVax(T) Collaboration with Sanofi-Aventis
|
|
12 Sep 2007 |
Opexa Therapeutics Gives Update on Phase IIb Trial of Tovaxin® for Treatment of Multiple Sclerosis
|
|
11 Sep 2007 |
TapImmune Inc. Announces Initiation of Testing on Novel Cancer Vaccine
|
|
11 Sep 2007 |
GenVec to Develop New Malaria Vaccine for the U.S Military
|
|
11 Sep 2007 |
Nventa initiates HspE7 Phase 1 Cervical Dysplasia Trial
|
|
08 Sep 2007 |
MedImmune Resolves FDA Observations Regarding Manufacturing Process for FluMist(R)
|
|
07 Sep 2007 |
Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
|
|
07 Sep 2007 |
Introgen's p53 Immunotherapy Drug Candidate to Advance Into Second Phase 2 Clinical Trial in Small Cell Lung Cancer With National Cancer Institute
|
|
06 Sep 2007 |
Merck: Stimuvax(R) Therapeutic Cancer Vaccine - Phase II Data Highlight Three-Year Survival Results for Lung Cancer Patients
|
|
06 Sep 2007 |
Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
|
|
04 Sep 2007 |
FDA Approves ACAM2000(TM) Vaccine for Protection against Smallpox
|
|
31 Aug 2007 |
Meridian Bioscience, Inc. Announces the Commencement of Phase I/II Clinical Trials of Parvovirus B19 Vaccine
|
|
29 Aug 2007 |
Vical Begins Phase 1 Trial of DNA Vaccine Against H5N1 Pandemic Influenza
|
|
28 Aug 2007 |
Immutep Announces That ImmuFact(R) IMP321 Has Entered a Phase I Lymphodepletion Therapeutic Vaccine Trial in Metastatic Melanoma
|
|
24 Aug 2007 |
Encouraging Phase II data on HIV vaccine utilizing GenVec technologies presented at Seattle AIDS conference
|
|
23 Aug 2007 |
Achievement in the Development of Hepatitis C Virus Vaccine
|
|
22 Aug 2007 |
Targeted Genetics reports interim Phase II data from HIV/AIDS vaccine clinical trial
|
|
21 Aug 2007 |
NasVax receives Ministry of Health approval for a Phase 1/2a clinical study for improved flu vaccine
|
